Hypothermic Ventricular Fibrillation in Redo Minimally Invasive Mitral Valve Surgery: A Promising Solution for a Surgical Challenge
Authors:
- Jawad SalmanJSJawad Salman
- Maximilian FranzMFMaximilian Franz
- Khalil AburahmaKAKhalil Aburahma
- Nunzio Davide de MannaNMNunzio Davide de Manna
- Saleh TavilSTSaleh Tavil
- Sadeq Ali-Hasan-Al-SaeghSASadeq Ali-Hasan-Al-Saegh
- Fabio IusFIFabio Ius
- Dietmar BoethigDBDietmar Boethig
- Alina ZubarevichAZAlina Zubarevich
- Bastian SchmackBSBastian Schmack
- Tim KaufeldTKTim Kaufeld
- Aron-Frederik PopovAron-Frederik Popov
Open Access
- 22 July 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4269
Abstract
Background: Minimally invasive mitral valve surgery (MIMVS) is a treatment for severe mitral valve pathologies. In redo cases, especially after coronary artery bypass grafting (CABG) surgery with patent mammary bypass grafts, establishing aortic clamping followed by antegrade cardioplegia application might be challenging. Here, we present the outcome of hypothermic ventricular fibrillation as an alternative to conventional cardioprotection. Methods: Patients who underwent MIMVS either received hypothermic ventricular fibrillation (study group, n = 48) or antegrade cardioprotection (control group, n = 840) and were observed for 30 postoperative days. Data were retrospectively analyzed and collected from January 2011 until December 2022. Results: Patients in the study group had a higher preoperative prevalence of renal insufficiency (p = 0.001), extracardiac arteriopathy (p = 0.001), insulin-dependent diabetes mellitus (p = 0.001) and chronic lung disease (p = 0.036). Furthermore, they had a longer surgery time and a lower repair rate (p < 0.001). No difference, however, was seen in postoperative incidences of stroke (p = 0.26), myocardial infarction (p = 1) and mitral valve re-operation (p = 1) as well as 30-day mortality (p = 0.1) and postoperative mitral valve insufficiency or stenosis. Conclusions: The patients who underwent redo MIMVS with hypothermic ventricular fibrillation did not have worse outcomes or more serious adverse events compared to the patients who received routine conventional cardioprotection. Therefore, the use of hypothermic ventricular fibrillation appears to be a promising cardioprotective technique in this challenging patient population requiring redo MIMVS.Keywords
This publication has 23 references indexed in Scilit:
- Clinical Impact of the Endo-aortic Clamp for Redo Mitral Valve SurgeryJournal of Cardiovascular Translational Research, 2024
- Late Survival After Redo Mitral Operation With Minithoracotomy Compared With SternotomyThe Annals of Thoracic Surgery, 2023
- Minithoracotomy vs Conventional Sternotomy for Mitral Valve RepairJAMA, 2023
- Clinical Outcomes of Mitral Valve Reoperations in the United States: An Analysis of The Society of Thoracic Surgeons National DatabaseThe Annals of Thoracic Surgery, 2019
- Minimally invasive right thoracotomy approach for mitral valve surgery in patients with previous sternotomy: A single institution experience with 173 patientsThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Beating heart surgery via right thoracotomy for reoperative mitral valve surgery: A safe and effective operative alternativeThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Echocardiography in mitral stenosisJournal of the Saudi Heart Association, 2011
- Retrograde Arterial Perfusion, Not Incision Location, Significantly Increases the Risk of Stroke in Reoperative Mitral Valve ProceduresThe Annals of Thoracic Surgery, 2010
- Axillary Cannulation Significantly Improves Survival and Neurologic Outcome After Atherosclerotic Aneurysm Repair of the Aortic Root and Ascending AortaThe Annals of Thoracic Surgery, 2008
- Does the Arterial Cannulation Site for Circulatory Arrest Influence Stroke Risk?The Annals of Thoracic Surgery, 2004